AHCO Shareholder Litigation A securities class action has been filed on behalf of all persons or entities who purchased or otherwise acquired: (i) AdaptHealth (NASDAQ: AHCO) common stock during the Class Period; and/or (ii) AdaptHealth common stock pursuant and/or traceable to the Company’s secondary public offering conducted on or around January 5, 2021.
The Complaint alleges that AdaptHealth, via certain of its senior executives orchestrated a scheme to overcharge CMS and other insurance providers by submitting improper billing codes for diabetes equipment. The Complaint further alleges that to facilitate this scheme, AdaptHealth and certain of its senior executives made numerous false and misleading statements to investors during the Class Period, and that as a result of these misrepresentations, AdaptHealth common stock traded at artificially inflated prices.
Current AdaptHealth shareholders who have held AdaptHealth since on or about the January 5, 2021 IPO, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award at no cost to them whatsoever.
If you would like to learn more about this matter, you are encouraged to contact us at jgrabar@grabarlaw.com, or call 267-507-6085.
https://grabarlaw.com/shareholder-derivative-actions/adapthealth-shareholder-investigation/